BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Schizophrenia

Below is an extended Schizophrenia research listing. Click here to return to the Schizophrenia main in depth entry.

Recent Publications on Schizophrenia:

[The regional psychiatry budget: costs and effects of a new multisector financing model for psychiatric care.]
OBJECTIVE To evaluate a new multi-sector financing model for psychiatric...
Direct Link
6th September, 2008
Universitat Leipzig, Professur fur Gesundheitsokonomie, Klinik fur
The Stigmatising Implications of Presenting Schizophrenia as a Genetic Disease.
This study aimed to investigate the hypothesis that belief in a genetic...
Direct Link
6th September, 2008
Institute of Medical Genetics, Cardiff University, Heath Park, Cardiff,
[Bilateral oedipism: a case report.]
Introduction: Oedipism (or self-enucleation) is a rare form of...
Direct Link
6th September, 2008
Service d'Ophtalmologie, Hopital Edouard Herriot, Hospices civils de Lyon,
Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats.
Previous clinical and animal studies suggest that selective activators of...
Direct Link
6th September, 2008
Vanderbilt University Med Ctr.
Serotonergic and dopaminergic modulation of attentional processes.
Disturbances in attentional processes are a common feature of several...
Direct Link
6th September, 2008
Department of Experimental Psychology and the Behavioural and Clinical
Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.
A close interplay exists between the serotonergic and dopaminergic...
Direct Link
6th September, 2008
Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline,
Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
Newer atypical antipsychotic drugs such as risperidone, olanzapine,...
Direct Link
6th September, 2008
Clinical Research Division, Hizen Psychiatric Center, 160 Yoshinogari,
In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
Atypical antipsychotic drugs related to clozapine, improve psychosis,...
Direct Link
6th September, 2008
Department of Psychiatry Vanderbilt, University School of Medicine,
Serotonin and dopamine interactions in psychosis prevention.
There has been significant recent growth in programmes evaluating...
Direct Link
6th September, 2008
Cincinnati Veterans Affairs Medical Center, Psychiatry Service (V116A),
Alterations of dopamine and serotonin transmission in schizophrenia.
The present chapter outlines current thinking regarding serotonin and...
Direct Link
6th September, 2008
Department of Psychiatry, Faculty of Medicine, University of Toronto,
Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment.
The prefrontal cortex (PFC) has attracted a great research interest...
Direct Link
6th September, 2008
Departament de Neuroquimica i Neurofarmacologia, Institut d'Investigacions
Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
In this review, the functional interactions between serotonin (5-HT) and...
Direct Link
6th September, 2008
Istituto di Ricerche Farmacologiche "Mario Negri", Consorzio Mario Negri
Serotonin-dopamine interaction: an overview.
Central serotonergic and dopaminergic systems play a critical role in the...
Direct Link
6th September, 2008
Istituto di Ricerche Farmacologiche "Mario Negri", Consorzio "Mario
Clinical practice of rTMS reveals a functional dissociation between agency and hallucinations in schizophrenia.
We report here the case of a hospitalized 11-year-old boy (YP) with a...
Direct Link
6th September, 2008
Universite Lille - Nord de France, CNRS UMR-8160, CHRU de Lille, 59037
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional